Midostaurin Modulates Tumor Microenvironment and Enhances Efficacy of Anti-PD-1 against Colon Cancer

SIMPLE SUMMARY: Colon cancer is one of the most common types of cancer worldwide. Immune checkpoint inhibitors have promising effects on various types of cancers with limited efficacy in colon cancer. Midostaurin (PKC412) is currently used for the treatment of patients with acute myeloid leukemia ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Cheng-Ta, Chi, Chih-Wen, Wu, Shu-Hua, Shieh, Hui-Ru, Yen, Jiin-Cherng, Chen, Yu-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563721/
https://www.ncbi.nlm.nih.gov/pubmed/36230769
http://dx.doi.org/10.3390/cancers14194847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563721/
https://www.ncbi.nlm.nih.gov/pubmed/36230769
http://dx.doi.org/10.3390/cancers14194847

Ejemplares similares